MRV Research

Targeting melanoma with peptide-conjugated nanoparticles

Ultrasmall gold nanoparticles (less 3 nm in diameter) are a promising therapeutic platform for cancer treatment due to their ability to accumulate in the nuclei of cells. Once inside cells, the nanoparticles can effectively deliver anticancer agents and simultaneously be used in radiotherapy for dose enhancement. However, achieving accumulation and retention of nanoparticles in tumours from systemic administration remains a challenge.

Read More

FIGHTING MELANOMA FROM THE INSIDE

IN the summer of 2004, few of the patients enrolling in Study 020 would have been thinking about sunny weather and days on the beach. Looming larger in their minds would have been the fact that within a year, three in every four of them were likely to be dead. All of them, from teenagers to seniors, had late-stage melanoma that chemotherapy could not help, and for which surgery could not be used. This trial was quite literally their last hope.

Read More
MRV News
Melanoma News
Archive
Menu